-
Cost Effectiveness Analysis of a Pharmacist-Led Clinical Decision Support System Powered by Machine Learning to Reduce Drug-Associated Acute Kidney Injury in the Adult Non-ICU Setting
Mar 10, 2025, 14:00 PM -
Economic Feasibility of 'Pay One Price': An Analysis of Three Biosimilar Molecules with Different Prices and Indicated for Rheumatoid Arthritis in a Medium Size HMO
Mar 10, 2025, 14:00 PM -
Economic Evaluation of Pneumococcal Vaccination Strategies Considering Cardiovascular Events and Antimicrobial Resistance in Colombian Adults Aged 50 and Older
Mar 10, 2025, 14:00 PM -
Attitude, Knowledge, and Intention to Receive Shingles Vaccine Using the Theory of Planned Behavior in Saudi Arabia
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns and Overall Survival (OS) of Patients With Metastatic Triple-Negative Breast Cancer (mTNBC) in Canada
Mar 10, 2025, 14:00 PM -
Anemia-Related Survival of Patients with Myelofibrosis: A Retrospective Real-World Study
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization and the Economic Burden of Neovascular Age-Related Macular Degeneration (nAMD): A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Reimbursement Outcomes for EMA Conditionally Authorized Orphan Drugs (2022-2023): Implications for Joint Clinical Assessment Requirements
Mar 10, 2025, 14:00 PM -
Healthcare Resource Optimization of Different Formulations: Daratumumab SC Compared To Daratumumab IV for Treating Multiple Myeloma
Mar 10, 2025, 14:00 PM -
Real-World Overall Survival of Multiple Myeloma Patients in a Colombian HMO During 2015-2023
Mar 10, 2025, 14:00 PM -
A Retrospective Cohort Study Evaluating the Association Between Fibrosis-4 Index and Major Adverse Cardiovascular Events in Patients with Metabolic Dysfunction-Associated Steatohepatitis
Mar 10, 2025, 14:00 PM -
JAV-RARAS: Value-Driven Care Journey in Patients with Duchenne Muscular Dystrophy: A Time-Driven Activity-Based Costing Study at the Bahiana School of Medicine and Public Health
Mar 10, 2025, 14:00 PM -
Analysis of Public Expenditure of Pharmaceutical Utilization of Female Infertility in Hungary in the Last Decade
Mar 10, 2025, 14:00 PM -
Economic Evaluation of Adjuvant Chemotherapy for Soft Tissue Sarcoma Using Linked NETSARC+ (French Registry) and SNDS (French National Health Data System) Real World Data: The Deepsarc Study
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization and Costs in Individuals Who Discontinue Liraglutide and Who Switch from Liraglutide to Once-Weekly Injectable Semaglutide
Mar 10, 2025, 14:00 PM -
Use of a Representative Sample of the French National Health Insurance Database (ESND) for Research: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Payer Perspectives on ICER Evidence Reports: InsightsInto Utility for Coverage and Formulary Decision-Making
Mar 10, 2025, 14:00 PM -
National Respiratory Surge Forecasting With Combined Pharmacy and Public Health Data
Mar 10, 2025, 14:00 PM -
Burden of Disease in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Mar 10, 2025, 14:00 PM -
Budget Analysis of Lenvatinib and Sorafenib as First-Line Treatments for Radioiodine-Refractory Differentiated Thyroid Cancer in the United States
Mar 10, 2025, 14:00 PM
